Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair
Recombinant factor VIIa (rFVIIa) after aortic valve replacement in a patient with osteogenesis imperfecta.
Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device.
Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa.
An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant Factor VII (Case Report)
Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery.
Prescribing Info - Questions - Drug Info - Links - PDA Software - Article Summaries - Slideshows - Review Articles - What's New
 
© Copyright 1999-2017 DocMD.com. All Rights Reserved.